Facebook
Instagram
Linkedin
Pinterest
Twitter
Youtube
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Tag: clinical study
Aimmune to Begin Phase 2 Trials of Egg Allergy OIT Candidate
News Wire ~ 3rd Party Press Release
-
2018/12/20
AR201 for Egg Allergy Phase 2 Initiation Planned for 2019.
Can Fecal Transplant Cure Peanut Allergy? Phase I Trial Underway
Dave Bloom
-
2018/11/07
Can transplanting the microbiota of a healthy person to that of an allergic individual prevent allergic reactions?
Aimmune Therapeutics Announces Initiation of Phase 2 Study of AR101 With...
News Wire ~ 3rd Party Press Release
-
2018/10/15
Trial Will Build on the Positive, Pivotal Phase 3 PALISADE Trial of AR101.
Phase II Trials of AR101 with Dupilumab for Peanut Allergy to...
Dave Bloom
-
2018/09/27
Study scheduled to commence next week.
Viaskin Peanut Completes Phase III Part A Study of Toddlers With...
News Wire ~ 3rd Party Press Release
-
2018/09/12
Part B expected to commence in 2018Q4 with Viaskin Peanut 250 µg.
Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate
Dave Bloom
-
2018/05/25
Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.
Study: Dupilumab Showed Positive Phase 3 Results in Adolescents with Inadequately...
News Wire ~ 3rd Party Press Release
-
2018/05/17
"[dupilumab] blocks the IL-4/IL-13 pathway, which is emerging as a central driver of Type 2 allergic inflammation."
Study: IgG Antibodies Activate Blood Platelets and Contribute to the Severity...
News Wire ~ 3rd Party Press Release
-
2018/05/16
"This work demonstrates the potential of exploring therapeutic interventions that target platelets as means of limiting the severity of anaphylactic shock."
Study: Pediatric Admissions Slashed With Simple Changes to Hospital Anaphylaxis Procedures
Dave Bloom
-
2018/04/05
Researchers were able to streamline the care of patients with anaphylaxis without any compromise in safety.
Study: Immunotherapy Trials for Food Allergy Hold Strong Appeal for Parents
Dave Bloom
-
2018/03/23
Child’s food allergies have major impact on parents’ lives; majority of parents are willing to enroll their child in an immunotherapy clinical trial
1
2
3
4
...
10
Page 3 of 10